Servier

Welcome to our page. Servier is committed to therapeutic progress to serve patient needs.

Servier is an independent international pharmaceutical group governed by a foundation. With its unique governance model, the Group is committed to therapeutic progress to serve patients and integrates the patient voice at every stage of the medicine life cycle. As a leading global player in cardiology and venous diseases, Servier aims to become a leading innovator in oncology and neurology. Through precision medicine, the Group intends to offer targeted therapeutic solutions for a limited number of rare diseases and invests nearly 20% of its brand-name sales in R&D. Headquartered in France, Servier relies on its more than 20,000 employees and a solid geographic presence with medicines distributed in more than 130 countries. In the 2024/25 financial year, the Group achieved revenues of €6.9 billion.

----

To report a suspected adverse event with a Servier drug 👉 https://bit.ly/435zpoI

13/04/2026

At a glance, in 2024-2025, Mécénat Servier was:
📌 5 areas of commitment,
📌 24 countries involved,
📌 20 nonprofit organizations supported,
📌 1,946 employee commitments,
📌 15 Sustainable Development Goals (SGDs) contributed to out of the 17 set by the UN for 2030.

Established in 2016, Mécénat Servier brings together the Group’s philanthropic and solidarity initiatives around one clear ambition: making a real, lasting impact.
Since its creation, we’ve supported 62 nonprofit organizations in 35 countries, responding to humanitarian emergencies, restoring access to healthcare, promoting equal opportunity, and strengthening civic engagement.

Read the Mécénat Servier 2024-2025 Annual Report 👉 https://mecenat.servier.com/2024-2025-annual-report/

12/04/2026

🌍 Growing in solidarity — together, we make a difference.
Since 2016, we have supported 62 nonprofit organizations across 35 countries. Our mission? To turn solidarity into concrete action.

The Mécénat Servier 2024–2025 Annual Report shows how, thanks to our employees and partners, we support vulnerable communities through both emergency response and long-term solutions.

In 2024–2025: 💙 1,946 employee commitments | 20 nonprofit organizations | 24 countries supported.

Behind these numbers are people — colleagues who choose to act, to help, and to build hope where it’s most needed.
Together, we’re building a fairer, more resilient world — one project, one community, one gesture at a time 🌱

Happy reading 👉 https://mecenat.servier.com/2024-2025-annual-report/

11/04/2026

🗣️ “It’s important to me to help people understand what Parkinson’s really is, and especially to break stereotypes— like the idea that it only affects older people and is only about tremors.”

To mark the , we had the pleasure of speaking 🗣️ with Valérie.

Valérie was only 44 when she was diagnosed with Parkinson’s disease — after years of symptoms, uncertainty, and misdiagnosis. Like many, she never imagined this condition could affect someone so young.

Through her journey, Valérie chose transparency, resilience, and sharing. As a mother, a patient, and now a voice for awareness, she reminds us how powerful understanding, support, and community can be.

🎥 Watch their inspiring story

You can also find Valérie - on Instagram.

10/04/2026

Parkinson’s disease remains a major scientific challenge. The disease is linked to the accumulation of abnormal proteins (alpha-synuclein) in the brain and the progressive loss of dopaminergic neurons. 🧠

⚠️ Despite available therapeutic solutions that help manage symptoms, none can slow or stop disease progression today. With cases expected to exceed 12 million worldwide by 2040, the need for innovation is more urgent than ever.

🧪 At Servier, we focus our research on identifying new therapeutic targets to slow disease progression and preserve patients’ autonomy.

👉 Discover more: servier.com

09/04/2026

🧠 Saturday is !
Let’s look beyond what we think we know about Parkinson’s disease.

While often associated with tremors, Parkinson’s is a complex neurodegenerative disorder that affects multiple functions — including sleep, mood, cognition, and digestion.
It is caused by the progressive degeneration of dopamine-producing neurons in the brain — and symptoms appear when more than 50% of these neurons are already lost.

📊 Today, more than 10 million people worldwide are living with Parkinson’s disease, making it the second most common neurodegenerative disorder after Alzheimer’s.

👉 Learn more: servier.com

08/04/2026

Life is full of changes, and every day is an opportunity to embrace the present and plan for the future. 🚀

by Servier supports Steven and helps you take control of your health journey by providing you with tools and information that enable you to live fully and confidently with your condition(s).

07/04/2026

Do you regularly forget to take your medication? 💊

🎥 Anca, health speaker and pharmacist, draws on international recommendations and scientific studies to give you the best advice as part of by Servier.

👉 Watch this video to discover her practical tips to help you stick to your treatment plan. 📋

Consult your doctor for further advice.

06/04/2026

Steven's words remind us that managing his condition goes far beyond prescriptions. It's about empowering people to take control of their daily actions. 💪

by Servier helps make this possible by connecting patients and professionals through data, information, and collaboration. Together, they can track progress, adapt care plans, and establish healthier routines that truly last.

05/04/2026

Managing one chronic disease is already challenging but managing several is even more complex 🔄.

Steven lives with diabetes, heart failure and sleep apnea conditions that interact and worsen each other. According to the American Diabetes Association, people with diabetes are 2 to 4 times more likely to develop cardiovascular diseases. This overlap of conditions is what healthcare calls comorbidities.

His journey highlights the need for integrated, patient-centered care approaches that consider the whole person rather than isolated diseases. This is what by Servier promotes: a holistic view of patient health.

04/04/2026

Globally, more than 589 million adults live with diabetes, a number expected to rise to 643 million by 2030. 🌍

For many, digital health solutions are transforming care.

Connected tools and apps can improve treatment adherence and empower patients. Ravi’s experience reflects this global shift: by tracking his health and sharing results with his doctor, he strengthens collaboration and reduces risks. His story illustrates how digital tools, when combined with reliable medical guidance, can truly change lives.

This is the mission of by Servier: focusing on improving patient control and empowerment over healthcare decisions and care.

03/04/2026

Michael’s experience highlights how health conditions can connect over time. What began with diabetes later involved cardiovascular and venous problems. These links are common, but knowing about them early makes a big difference.

Michael’s story shows that every step counts monitoring blood sugar, following medical advice, adjusting nutrition, staying active and resting well. Patients who combine these approaches report better well-being and more confidence in their daily life.

Healthcare teams, supported by by Servier, work together to support patients living with multiple conditions, helping them to better understand and manage their health on a daily basis. 💙

02/04/2026

To mark the World Autism Awareness Day, we had the pleasure of speaking 🗣️ with Violet and her family.

Violet shares her journey living with autism, her difficulties and strengths, and how it impacts her family life. Her daughter Summer also has autism, and they tell us more about their daily life and relationship, as an autistic family.

Their message is clear: Autistic people are all unique and should be accepted for who they are!

🎥 Watch their inspiring story in this video

You can also find on Instagram.

Adresse

50, Rue Carnot
Suresnes
92150

Téléphone

+33 1 55 72 60 00

Site Web

https://servier.com/

Notifications

Soyez le premier à savoir et laissez-nous vous envoyer un courriel lorsque Servier publie des nouvelles et des promotions. Votre adresse e-mail ne sera pas utilisée à d'autres fins, et vous pouvez vous désabonner à tout moment.

Raccourcis

Vous voulez que votre pratique soit Clinique la plus cotée à Suresnes ?

Type

Centre de recherche médicale

Our Story

Servier is an international pharmaceutical company governed by a non-profit foundation, with headquarters in Suresnes, France.

With a strong international presence in 149 countries and a turnover of € 4.2 billion in 2018, Servier employs 22.000 people worldwide.

Entirely independent, Servier reinvests 25% of its revenue (excluding generic drugs) in research and development and uses all its profits for development.